Related Experiment Videos
A discussion of modalities for assessing regression and progression in vascular disease
1University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. don.black@mrlinternational.com
The American Journal of Cardiology
|March 7, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
European heart journal·2022
Advancing Beyond Failed High-density Lipoprotein Clinical Trials to Pharmacogenetic Studies of ADCY9 and Cholesterol Ester Transfer Protein Inhibition.
Journal of cardiovascular pharmacology·2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.
Circulation. Genomic and precision medicine·2021
Outcomes After Percutaneous Transcatheter Release Or Fibrinolysis For Obstructive Mechanical Mitral Valve Thrombosis.
The American journal of cardiology·2026